Evidence map›Paper›PMID 36606310›Full record

ArticleJournal of cellular and molecular medicine2023

HRAS mutation positive multiple myeloma in the type 2 CALR mutation positive essential thrombocythemia: A case report.

Krzysztof Lewandowski, Agata Kopydłowska, Zuzanna Kanduła, Bartłomiej Sankowski, Marcin Machnicki, Marta Barańska, Kinga Gwóźdź-Bąk, Tadeusz Kubicki, Anna Płotka, Łucja Przysiecka and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cellular and molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Krzysztof LewandowskiDepartment of Hematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.ORCID 0000-0003-0992-2020
Agata KopydłowskaDepartment of Hematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.
Zuzanna KandułaDepartment of Hematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.ORCID 0000-0003-3734-271X
Bartłomiej SankowskiDepartment of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland.
Marcin MachnickiDepartment of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-8525-543X
Marta BarańskaDepartment of Hematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.
Kinga Gwóźdź-BąkDepartment of Hematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.ORCID 0000-0002-0494-9833
Tadeusz KubickiDepartment of Hematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.
Anna PłotkaORCID 0000-0001-9519-1695
Łucja PrzysieckaNanoBioMedical Centre, Adam Mickiewicz University in Poznań, Poznań, Poland.ORCID 0000-0001-7728-6711
Grzegorz DworackiDepartment of Clinical Pathology, Poznań University of Medical Sciences, Poznań, Poland.
Piotr KozłowskiLaboratory of Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.ORCID 0000-0003-3770-7715
Tomasz StokłosaDepartment of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-6918-5056
Poznan University of Medical Sciences · PLMedical University of Warsaw · PLAdam Mickiewicz University in Poznań · PLInstitute of Bioorganic Chemistry, Polish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Out of BCR-ABL negative myeloproliferative neoplasm (MPNPh

Indexed as

Multiple MyelomaMyeloproliferative DisordersThrombocythemia, EssentialCalreticulinGenomic InstabilityHumansJanus Kinase 2Middle AgedMutationProto-Oncogene Proteins p21(ras)CalreticulinHRAS protein, humanJanus Kinase 2Proto-Oncogene Proteins p21(ras)CALRessential thrombocythemiaHRASmultiple myeloma

Identifiers

PMID36606310
PMCPMC9843526
OpenAlexW4313647236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.